Lifeng Luo, Ph.D.

Affiliations: 
2003 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Environmental Sciences, Hydrology
Google:
"Lifeng Luo"

Parents

Sign in to add mentor
Alan Robock grad student 2003 Rutgers, New Brunswick
 (Evaluation of land surface models using ground-based point -scale measurements.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wu HY, Luo LF, Wei F, et al. (2023) Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma. World Journal of Surgical Oncology. 21: 366
Tao F, Ye Q, Chen Y, et al. (2023) Antigen-loaded flagellate bacteria for enhanced adaptive immune response by intradermal injection. Journal of Controlled Release : Official Journal of the Controlled Release Society
Luo L, Zhang B, Tao F, et al. (2023) Perfluorotributylamine-Loaded Albumin Nanoparticles Downregulate Platelet-Derived TGFβ to Inhibit Tumor Metastasis. Acs Nano. 17: 15388-15400
Luo L, Chen Z, Gong T, et al. (2023) Cytosolic perfluorocarbon delivery to platelets via albumin for antithrombotic therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society
Bao Z, Luo L, Xu T, et al. (2022) Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study. Annals of Translational Medicine. 10: 967
Yang J, Zeng R, Zhou J, et al. (2022) Efficacy, prognosis and safety analysis of anti-PD-1/PD-L1 inhibitor rechallenge in advanced lung cancer patients: a cohort study. Translational Lung Cancer Research. 11: 1038-1050
Wang C, Wang H, Luo L, et al. (2022) Scintillator-based radiocatalytic superoxide radical production for long-term tumor DNA damage. Biomaterials Science
Zeng R, Luo L, Sun X, et al. (2021) EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAF mutation: a case report and review of literature. Cancer Drug Resistance (Alhambra, Calif.). 4: 1019-1027
Zeng R, Liu F, Fang C, et al. (2021) PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients. Frontiers in Immunology. 12: 724443
Hatami Bahman Beiglou P, Luo L, Tan PN, et al. (2021) Automated Analysis of the US Drought Monitor Maps With Machine Learning and Multiple Drought Indicators. Frontiers in Big Data. 4: 750536
See more...